Click here to read the full article.
A low dose of the Pfizer-BioNTech COVID-19 vaccine didn’t produce a significant immune response among children between the ages of 2 and 5, the two firms said on Friday.
Amid clinical trials that are ongoing, the two drugmakers tested 3 micrograms of the vaccine in kids aged 6 months to less than 5 years of age. Children between 6 months and 2 years produced an immune response comparable to individuals aged 16 to 25 years after two doses of the mRNA vaccine, the companies said.
However, the vaccine didn’t produce a significant immune response after the same dose regimen among children between the ages of 2 and 4, according to the companies. Pfizer and BioNTech said they will change their plans and will test three doses of their COVID-19 vaccine on children in that age group rather than the usual two doses.
Continue reading here.
Scroll down for comments and share what’s on your mind.
GIPHY App Key not set. Please check settings